Market Tracker

06/30 5:16pm ET

Depomed Inc (NASDAQ:DEPO)

19.62
Delayed Data
As of 4:00pm ET
 +0.20 / +1.03%
Today’s Change
12.25
Today|||52-Week Range
33.74
+8.22%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close19.42
Today’s open19.25
Day’s range18.53 - 19.66
Volume1,904,070
Average volume (3 months)1,852,006
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+71.80%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.75

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-0.23-0.77%
OASMOasmia Pharmaceutica...+0.10+3.01%
VBLTVascular Biogenics L...+0.46+11.08%
DNAIProNAi Therapeutics ...-0.03-1.49%
Data as of 4:00pm ET, 06/30/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts